Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Jamil S. Oliveira"'
Autor:
Ana Carolina R. Oliveira, Flávia Santiago De Oliveira, Ana Flávia Bráz, Jamil S. Oliveira, Jane Lima-Santos, Adriana A. M. Dias
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The discovery of new therapeutic alternatives for cancer treatment is essential for improving efficacy and specificity, overcoming resistance, and enabling a more personalized approach for each patient. We investigated the antitumor activity of the c
Externí odkaz:
https://doaj.org/article/320d24a3270d49c8a7abb87cc34d9dfd
Autor:
Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel S. Dias, Débora V.C. Mendonça, Fernanda F. Ramos, Lívia M. Carvalho, Bethina T. Steiner, Grasiele S.V. Tavares, Vívian T. Martins, Amanda S. Machado, João A. Oliveira-da-Silva, Thaís T.O. Santos, Camila S. Freitas, Jamil S. Oliveira, Bruno M. Roatt, Ricardo A. Machado-de-Ávila, Maria V. Humbert, Myron Christodoulides, Eduardo A.F. Coelho
Publikováno v:
Vaccines, Vol 8, Iss 2, p 289 (2020)
Background: Leishmaniases are neglected diseases caused by infection with Leishmania parasites and there are no human vaccines in use routinely. The purpose of this study was to examine the immunogenicity of ChimeraT, a novel synthetic recombinant va
Externí odkaz:
https://doaj.org/article/0d348c69932349ab9c3924f3d9114030
Autor:
Daniela P. Lage, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Flávia P. Linhares, Jamille M.O. Cardoso, João A. Oliveira-da-Silva, Fernanda F. Ramos, Isabela A.G. Pereira, Fernanda Ludolf, Grasiele S.V. Tavares, Raquel S. Bandeira, Jamil S. Oliveira, Daniel Menezes-Souza, Mariana C. Duarte, Alexsandro S. Galdino, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Molecular Immunology. 155:79-90
Autor:
Jaqueline S. Moreira, Jamil S. Oliveira, Marcelo P. Bemquerer, Ricardo A. Machado-de-Ávila, Daniel M. Santos, Desielle C. Matos, Bruna T. Maria, Paula P. Magalhães, Luiz M. Farias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9088a9c549c158358821ecb086056d7
https://doi.org/10.22533/at.ed.4402229092
https://doi.org/10.22533/at.ed.4402229092
Autor:
Nathalia Sthefanie Ricardo da Silva, Mariluce Mazetto de Araujo, André Belico de Vasconcelos, Jamil S. Oliveira, Amanda Pifano Neto Quintal, Luiz Alfredo Garcia Deragon
Publikováno v:
Brazilian Journal of Animal and Environmental Research. 4:1874-1882
O fluido seminal é o componente liquido do esperma que proporciona um ambiente seguro para os espermatozoides. O estudo dos componentes do plasma seminal bovino, em especifico as proteínas são apontadas como uma estratégia de buscar biomarcadores
Autor:
Jamil S. Oliveira, Myron Christodoulides, Ricardo Andrez Machado-de-Ávila, Patrícia A.F. Ribeiro, Lívia M. Carvalho, Bethina T. Steiner, Vívian T. Martins, Grasiele S.V. Tavares, Daysiane de Oliveira, Luísa Perin, Thaís T.O. Santos, Fernanda F. Ramos, Eduardo A.F. Coelho, Daniel Dias, Débora V.C. Mendonça, Bruno Mendes Roatt, Daniela P. Lage, Antônio Lúcio Teixeira, Amanda S. Machado, Maria Victoria Humbert, João A. Oliveira-da-Silva
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-13 (2020)
Leishmaniases are neglected diseases caused by infection with Leishmania parasites and there are currently no prophylactic vaccines. In this study, we designed in silico a synthetic recombinant vaccine against visceral leishmaniasis (VL) called Chime
Autor:
Amanda S. Machado, Daniela P. Lage, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M.O. Cardoso, Isabela A.G. Pereira, Fernanda F. Ramos, Grasiele S.V. Tavares, Fernanda Ludolf, João A. Oliveira-da-Silva, Raquel S. Bandeira, Aratti C. Simões, Mariana C. Duarte, Jamil S. Oliveira, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Acta tropica. 230
Vaccination against visceral leishmaniasis (VL) should be considered as a control measure to protect against disease, and amastigote-specific proteins could help to develop such vaccines, since this parasite form is in contact with the host immune sy
Autor:
Daniela P. Lage, Amanda S. Machado, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M.O. Cardoso, Isabela A.G. Pereira, Fernanda F. Ramos, Grasiele S.V. Tavares, Fernanda Ludolf, João A. Oliveira-da-Silva, Raquel S. Bandeira, Alessandra M. Silva, Luciana C. Simões, Thiago A.R. Reis, Jamil S. Oliveira, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Cytokine. 153
Leishmania virulence proteins should be considered as vaccine candidates against disease, since they are involved in developing infection in mammalian hosts. In a previous study, a Leishmania guanosine-5'-triphosphate (GTP)-binding protein was identi
Autor:
Luiz de Macêdo Farias, Paula Prazeres Magalhães, Simone Gonçalves dos Santos, Marcela Nascimento Pinheiro Braga, Natália Rocha Guimarães, Marcelo P. Bemquerer, Jamil S. Oliveira
Publikováno v:
Brazilian Journal of Development. 5:32316-32345
The indigenous microbiota of humans is extremely rich and diverse, with special emphasis on the intestinal microbiota. As a constituent of this microbiota, it is mentioned the genus Bacteroides, whose members are Gram negative rods, obligate anaerobe
Autor:
Daniel Dias, Débora V.C. Mendonça, Daniela P. Lage, Marcus V. M. Novais, Grasiele S.V. Tavares, Mariana C. Duarte, Eduardo A.F. Coelho, Bruno Mendes Roatt, Carlos Alberto Pereira Tavares, Mônica Cristina de Oliveira, Miguel A. Chávez-Fumagalli, Jamil S. Oliveira, Patrícia A.F. Ribeiro, Fernanda Ludolf, Daniel Menezes-Souza
Publikováno v:
Cytokine. 111:131-139
Leishmania proteins have been evaluated as vaccine candidates against leishmaniasis; however, most antigens present low immunogenicity and need to be added with immune adjuvants. A low number of licensed adjuvants exist on the market today; therefore